(Allergan plc)

	AGN latest price $184.6648 (-0.63%) ($183.2557 - $186.6434) on Tue. Dec. 20, 2016.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.14% (three month average)
RSI	42
Latest Price	$184.6648(-0.63%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -0.2% a day on average for past five trading days.
Weekly Trend	AGN advances 0.3% a week on average for past two weeks.
Market Behavior	Broad based rally for large cap. Broad based rally for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(50%)    XLV(49%)    XBI(44%)    SPY(43%)    VT(43%)
Factors Impacting AGN price	AGN will decline at least -1.07% in a week (0% probabilities).   VIXM(-29%)    TLT(-15%)    UUP(-14%)    SHY(-3%)    IPO(-3%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.07% (StdDev 2.14%)
Hourly BBV	0 ()
Intraday Trend	-0.9%

Resistance Level	$184.83
5 Day Moving Average	$185.64(-0.53%)
10 Day Moving Average	$185(-0.18%)
20 Day Moving Average	$184.83(-0.09%)
To recent high	-21.6%
To recent low	1.5%
Market Cap	$60.884b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed